(NRIX) Nurix Therapeutics - Performance -40.4% in 12m
NRIX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-49.40%
#66 in Peer-Group
Rel. Strength
12.21%
#6757 in Stock-Universe
Total Return 12m
-40.44%
#116 in Peer-Group
Total Return 5y
-35.77%
#50 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 28.14 USD |
| 52 Week Low | 8.81 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 62.40 |
| Buy/Sell Signal +-5 | -1.12 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: NRIX (-40.4%) vs XBI (-9.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-1.02% | 69.7% | 77.8% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-10.4% | -7.09% | 151% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.42% | -1.57% | 39.4% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.65% | 30.3% | -1.81% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.39% | -9.49% | -0.73% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
10.5% | 38.7% | -6.49% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-7.82% | 50.2% | -13.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.95% | 29.1% | 18.3% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: NRIX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for NRIX
| Total Return (including Dividends) | NRIX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -2.63% | 0.53% | 3.75% |
| 3 Months | 31.86% | 21.37% | 25.32% |
| 12 Months | -40.44% | -9.11% | 13.11% |
| 5 Years | -35.77% | -25.99% | 109.78% |
| Trend Score (consistency of price movement) | NRIX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -20.5% | -5.7% | 80.3% |
| 3 Months | 66.8% | 79.4% | 97.2% |
| 12 Months | -85.2% | -86.9% | 45.4% |
| 5 Years | -53.5% | -52.2% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th48.50 | -3.15% | -6.15% |
| 3 Month | %th58.00 | 8.64% | 5.22% |
| 12 Month | %th42.50 | -34.47% | -47.34% |
| 5 Years | %th76.50 | -15.24% | -69.07% |
FAQs
Does Nurix Therapeutics (NRIX) outperform the market?
No,
over the last 12 months NRIX made -40.44%, while its related Sector, the SPDR S&P Biotech (XBI) made -9.11%.
Over the last 3 months NRIX made 31.86%, while XBI made 21.37%.
Performance Comparison NRIX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
NRIX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 3.8% | -6.4% | -43.3% | -54% |
| US NASDAQ 100 | QQQ | 3.3% | -6.8% | -44.9% | -52% |
| German DAX 40 | DAX | 2% | -2.8% | -56.1% | -71% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 2.7% | -6.4% | -47% | -62% |
| Hongkong Hang Seng | HSI | 4.3% | -5.7% | -63.8% | -79% |
| India NIFTY 50 | INDA | 4.5% | -3.4% | -43.8% | -39% |
| Brasil Bovespa | EWZ | 4.6% | -8.5% | -65.3% | -48% |
NRIX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 5.2% | -6.1% | -47.8% | -65% |
| Consumer Discretionary | XLY | 4.5% | -4.6% | -35.5% | -56% |
| Consumer Staples | XLP | 5% | -3% | -43.8% | -48% |
| Energy | XLE | 0.7% | -9.4% | -39.6% | -43% |
| Financial | XLF | 5.1% | -5.4% | -45.9% | -68% |
| Health Care | XLV | 5.5% | -3.7% | -34.4% | -36% |
| Industrial | XLI | 3.7% | -5.8% | -50.2% | -65% |
| Materials | XLB | 3% | -6.4% | -46.9% | -46% |
| Real Estate | XLRE | 4.9% | -2.5% | -42.2% | -52% |
| Technology | XLK | 2.2% | -9.8% | -47.4% | -51% |
| Utilities | XLU | 5.3% | -3.9% | -45.7% | -62% |
| Aerospace & Defense | XAR | 3.1% | -6.4% | -61.5% | -88% |
| Biotech | XBI | 2.3% | -3.2% | -29.2% | -31% |
| Homebuilder | XHB | 5.1% | -8.6% | -35.4% | -44% |
| Retail | XRT | 3.7% | -4.2% | -38.6% | -50% |
NRIX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 0.2% | -9.44% | -37.0% | -36% |
| Natural Gas | UNG | 6.1% | 7.8% | -24.1% | -34% |
| Gold | GLD | 5.4% | -1.8% | -61.1% | -80% |
| Silver | SLV | 2.6% | -2.3% | -58.9% | -59% |
| Copper | CPER | -2.7% | -12.7% | -63.7% | -59% |
NRIX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 6.7% | -3.7% | -39.6% | -37% |
| iShares High Yield Corp. Bond | HYG | 4.5% | -3.9% | -41.7% | -50% |